Creatinine Measurement Market Size, Share, and Industry Analysis By Product (Devices and Consumables (Kits & Reagents)), By Method (Calorimetric Method and Enzymatic Method), By Sample Type (Blood/Serum and Urine), By End-user (Hospitals, Diagnostic Laboratories, and Others), and Regional Forecast till 2032

The global creatinine measurement market expands due to the rising global burden of kidney diseases and chronic conditions. Creatinine measurement products are a type of diagnostic product, including the creatinine measurement kit, reagent, and instrument (clinical analyzer, test strip, and cartridge), which are used to detect the level of creatinine in biological fluid (blood serum/plasma and urine).

The market for creatinine measurements is shifting significantly with the inventions of highly diagnostic technologies. This has seen the development of automated analyzers to assist in improving efficiency and turnaround time in laboratories so that they are able to screen high throughput.

Creatinine Measurement Market Driver

Rise in Prevalence of CKD to the Defense Ministry to Expand the Market

A major trigger is the rise in the prevalence of chronic kidney disease (CKD) in all parts of the globe. CKD is a gradual-onset illness where kidneys gradually lose their ability to filter the waste products in blood, and early detection and management are highly pertinent in controlling the condition and its complications, including end-stage renal disease.

Ageing Population to Advance the Market

An ageing population is a powerful demographic determinant that powers the creatinine measurement market. It is natural that with age the threat of the occurrence of a range of chronic diseases, one of which is kidney dysfunction, grows. Even in healthy individuals, kidney functionality is likely to decline with age; therefore, senior individuals are at high risk of CKD.

Creatinine Measurement Market Restraint

Emergence of Alternative Biomarkers toPose Potential Impediments on this Market

Even though the creatinine testing maintains its status as one of the staples of the kidney function tests, the market is somewhat dampened by the possibility of other biomarkers. In its entire usage, creatinine is not devoid of shortcomings, as its level might be influenced by some non-renal factors such as muscle bulk, diet, age, and drugs, among others, thereby providing an inaccurate determination of the glomerular filtration rate (GFR) in the prevalent populations.

Creatinine Measurement Market Opportunity

Emerging Markets to Create Opportunity in this Market

One of the major opportunities that the creatinine measurement market has had is its penetration into emerging markets. Asia-Pacific, Latin American and African countries are growing economically at a high rate; healthcare infrastructure is also growing and access to diagnostic services is rising. This is alongside an increase in the burden of chronic illnesses such as diabetes and hypertension, the major risk factors of CKD.

Segmentation

Key Insights

The report covers the following key insights:

• Market drivers, restraints and opportunities
• Influence of key industrial players and key developments
• Rising Global Burden of Kidney Diseases
• Technological Advancements

Analysis by Product

By Product, the Creatinine Measurement market is divided into Devices, Consumables, Kits & Reagents

The devices section of the creatinine measurement market mostly comprises clinical analysers, point-of-care (POCT) devices, and other related special equipment utilised in carrying out creatinine tests. This is a rapidly growing segment because of the technological developments which are taking place in the diagnostic equipment.

The growth in the "Consumables" segment is mainly owing to the volume-based growth in creatinine testing on account of the increasing incidences of chronic kidney disease and an ageing world population, as highlighted previously.

Analysis by Method

Based on Method, the market is divided into Calorimetric Method & Enzymatic Method

The calorimetric method market is still growing because of its low cost and high availability, which make it especially appealing in resource-constrained environments and as a front-line screen in large diagnostic labs worldwide.

Enzymatic creatinine assay is based on a sequence of enzymatic reactions, which transform creatinine into a measurable product, usually by using enzymes such as creatininase, creatinase and sarcosine oxidase. The reason why the procedure is growing greatly in utilisation is that it has a higher level of specificity and fewer interferences than the Jaffe method.

Analysis by Sample Type

Based on Sample Type, the market is divided into Blood/Serum & Urine

The innovations in automated clinical analysers, as well as the growing popularity of point-of-care testing (POCT) devices that use small blood volumes (such as fingerstick), have made blood creatinine testing much more accessible and convenient, with quick test results available in many health care facilities, and this factor generates a significant portion of the market growth.

The rising concern about early identification of kidney issues and the expanding awareness of the prognostic significance of urine biomarkers are major factors fuelling the requirement of urine creatinine measurements, thus playing a role in the growth of this segment, especially to determine an overall kidney health status.

Analysis by End-user

Based on End-user, the market is divided into Hospitals, Diagnostic Laboratories & Others

The epidemic of chronic kidney disease (CKD), diabetes, and hypertension occurring globally in direct proportion raises the volume of creatinine tests carried out in hospital establishments to screen, identify, and follow up.

By volume, independent and hospital-based diagnostic laboratories are an important part of the creatinine measurement market development due to the large number of tests they perform, in addition to their experience.

Regional Analysis

To gain extensive insights into the market, Download for Customization

Based on region, the Creatinine Measurement market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America dominates the market of creatinine measurement, and its role is major due to several factors. The region is well equipped with a healthcare system regarding infrastructural diagnosis and has embarked on a massive automation of laboratory services. In countries like the United States and Canada, chronic kidney disease (CKD), diabetes, and hypertension are very common, which makes routine creatinine tests, which are applied in screening, diagnosis, and management of the disease, very necessary and demanded.

• According to U.S. Centers of Disease Control and Prevention, 15400 U.S. hospitals were performing creatinine tests weekly in 2023.
• According to U.S. Food and Drug Administration, 12480 Labs were using enzymatic creatinine assays in 2023.

Europe is another significant market in the measurement of creatinine, where the situation is influenced by the presence of the well-elaborated healthcare system and the aged population. Like North America, the increasing incidence of CKD and other chronic disorders is among the threatening factors that generate constant demand for creatinine tests on the continent. The European countries are characterised by having highly established public health and regulatory policies, emphasising early disease detection and preventive health, which contributes to the explainability of the broad application of creatinine tests.

Asia Pacific is emerging as a high-growth market in creatinine measurement and is increasingly leaving its mark on the global front too. The key drivers to this growth remain the enormous population of the area, rising disposable income and the enormous gain in healthcare facilities. Diabetes and hypertension are lifestyle-related diseases that are rising to an alarming proportion in countries like China and India because of the high population growth and demand for diagnostic testing in the countries.

Key Players Covered

The report includes the profiles of the following key players:

• Nova Biomedical (U.S.)
• Hoffmann-La Roche Ltd (Switzerland)
• Abbott (U.S.)
• DH Life Sciences, LLC (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Siemens Healthcare Private Limited (India)
• SENTINEL (California)

Key Industrial Developments

• In June 2022 Nova Biomedical recently made a huge contribution to the point-of-care (POC) diagnostics market by introducing its CE-marked Nova Max Pro Creatinine/eGFR Meter System in the EU. The revolutionary handheld device will make a difference in kidney care by offering rapid, precise, and simple screening and early diagnosis of kidney disease beyond the conventional hospital structure.
• In July 2022, Creative Enzymes, a leading company in enzyme-related products and services, probably strengthened the enzymatic method segment of the creatinine measurement market (details of a new enzyme product offering to measure creatinine in July 2022 are not easily found in open searches; however, Creative Enzymes is a leading company in enzyme-related products and services).